ARCHIVES

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

Gene Vector Labs Seek Vector Producers

February 23, 1996

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

New Treatment Approach To Treating Brain Tumor

April 26, 2002

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005